Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Nivaquine*


May be acceptable

May be acceptable
Nivaquine* :
Type Medicine Non Marketed
Originator B
Agent Mersaco
Distributor Mersaco
Laboratory Sanofi
Responsible Party Sanofi Aventis France
Origin France
Manufacturer Famar Lyon
Origin France
ATC P01BA01

Your comment will appear shortly after approval

Nivaquine* :

Revision Date : 30/11/2015


Effect Frequency
Accommodation disorder Common
Aggressiveness Rare
Agitation Rare
Agranulocytosis Very rare
Alopecia Rare
Anaphylactic reactions Common
Anaphylactoid reactions Common
Angioedema (Angioneurotic oedema) (Quincke oedema) Common
Anxiety Rare
Arrhythmia Not known
Cardiac failure Very rare
Cardiomyopathy Very rare
Cephalea Very Common
Confusion Rare
Convulsion Very rare
Corneal opacity Rare
Deafness Very rare
Depression Common
Dermatitis exfoliative Not known
DRESS (Drug reaction with eosinophilia and systemic symptoms) Not known
Dyskinesia Not known
Dystonia Not known
Eosinophilic pneumonia Very rare
Erythema multiforme Not known
Extrapyramidal disorder Not known
Gastrointestinal discomfort Very Common
Hallucination Rare
Hepatic enzyme increased Very rare
Hepatitis Very rare
Hypoacusis Very rare
Hypoglycaemia Not known
Insomnia Very Common
Lightheadedness Common
Lyell Syndrome (Toxic epidermal necrolysis) Very rare
Macular degeneration Not known
Maculopathy Not known
Mucosal pigmentation Rare
Myopathy Rare
Nail pigmentation Rare
Nausea Very Common
Neuropathy Rare
Neutropenia Very rare
Photosensitivity Very rare
Pigmentation disorder Rare
Polyneuritis Rare
Protrusion tongue Not known
Pruritus Very Common
Psoriasis exacerbation Rare
Psychotic episode Very rare
QT interval prolonged (QT prolongation) Not known
Retinopathy Not known
Skin Eruption Common
Sleep disorder (Sleep disturbance) Rare
Stevens-Johnson syndrome Very rare
Suicidal behaviour Not known
Thrombocytopenia (Thrombopenia) Very rare
Tinnitus Very rare
Torsade de pointes Not known
Torticollis Not known
Ventricular fibrillation Not known
Ventricular tachycardia Not known
Vision blurred Common
Vomiting Very Common

Different Units By MoH Code

Revision Date : 01/09/2000

Revision Date : 01/05/2008

Nivaquine* Nivaquine* Nivaquine* Nivaquine* Nivaquine* Nivaquine*

Nivaquine*  MoH 1760 :
Form Tablet
Packaging Blisters (Al/PVC)
Package Size Box of 20
Strength 100mg
NSSF ✘
Quarantine ✘
Reg. Number 1838/72
Submission date 01/01/1972
Registration Year 1972
Archived Date 01/03/2022


Price Comparison

● Country: Tunisia
● Package Size: Boîte de 20
● Public Price: 7.5 TND ( 216,487.50 LBP )
● Pack size unit used: 20
● Cost/Unit: 0,375 TND ( 0.00 LBP )
● Pricing Date: 04/02/2019
● Type: Medicine Authorised

● Country: France
● Package Size: 20
● Public Price: 3.16 EUR ( 306,128.16 LBP )
● Pack size unit used: 20
● Cost/Unit: 0,158 EUR ( 0.00 LBP )
● Reference: ansm
● Pricing Date: 15/05/2021
● Type: Medicine Authorised

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info